Glenmark Pharmaceuticals Q2 Results
- BSE: 532296
- NSE: GLENMARK
- ISIN: INE935A01035
- Sector: Biotechnology & Drugs
BSE
1,493.45
13.40 (0.91%)
13.40 (0.91%)Volume12.74 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,490.412.20 (0.83%)
12.20 (0.83%)Volume8.17 L
Updated: Mon 25 Nov, 2024 | 15:31:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹3,433.80 Cr.(5.84%)
- Operating Profit₹481.63 Cr.(2.38%)
- Profit After Tax₹354.21 Cr.(4.10%)
- Operating Margin14.03%(NA%)
Note: Comparison is on YoY basis
Quarterly - Glenmark Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3,433.80 | 3,036.07 | -% | 3,207.38 | -% |
| Selling/ General/ Admin Expenses Total | 786.56 | 681.27 | -% | 732.88 | -% |
| Depreciation/ Amortization | 120.28 | 142.04 | -% | 141.45 | -% |
| Other Operating Expenses Total | 975.24 | 729.64 | -% | 814.43 | -% |
| Total Operating Expense | 2,952.16 | 2,792.78 | -% | 3,211.97 | -% |
| Operating Income | 481.63 | 243.29 | -% | -4.59 | -% |
| Net Income Before Taxes | 472.57 | 151.40 | -% | -124.35 | -% |
| Net Income | 354.21 | 149.93 | -% | -81.95 | -% |
| Diluted Normalized EPS | 12.55 | 1.71 | -% | 0.38 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST